Alleviant Medical Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $13M
Latest Deal Amount
  • Investors
  • 11

Alleviant Medical General Information

Description

Developer of medical devices designed to offer treatment for congestive heart failures. The company's device relieves pressure buildup in the left atrium of the heart that can possibly lead to organ failures, thereby enabling hospitals to provide symptomatic relief and appropriate treatments to their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 7801 North Lamar Boulevard
  • Suite D-106
  • Austin, TX 78752
  • United States

Alleviant Medical Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alleviant Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Early Stage VC (Series B) 05-Nov-2020 $13M 000.00 0000 Completed Clinical Trials - Phase 1
8. Early Stage VC (Series A) 01-Apr-2019 00.00 00.00 000.00 Completed Pre-Clinical Trials
7. Early Stage VC (Series A2) 30-Mar-2018 00.000 00.000 00.000 Completed Pre-Clinical Trials
6. Grant 01-Jan-2018 00000 Completed Product In Beta Test
5. Accelerator/Incubator 26-Sep-2017 Completed Product In Beta Test
4. Accelerator/Incubator 23-May-2017 Completed Product In Beta Test
3. Grant 06-Apr-2017 000 Completed Product In Beta Test
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2017 Completed Startup
To view Alleviant Medical’s complete valuation and funding history, request access »

Alleviant Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Alleviant Medical’s complete cap table history, request access »

Alleviant Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of medical devices designed to offer treatment for congestive heart failures. The company's device relieves pr
Therapeutic Devices
Austin, TX
15 As of 2021
000.00
000 0000-00-00
00000000000 000.00

000000 0

oluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pr
00000000000 0000000
Los Gatos, CA
00 As of 0000
0000
0000 0000-00-00
00000000000 0000

0000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur si
00000000 0000000
Kirkland, WA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alleviant Medical Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Supira Medical Venture Capital-Backed Los Gatos, CA 00 0000 00000000000 0000
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
000000000 Venture Capital-Backed Houston, TX 00 000.00 00000000000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Alleviant Medical Executive Team (5)

Name Title Board Seat Contact Info
Adam Berman Chief Executive Officer, President and Board Member
Albertien Greijdanus Co-Founder & Vice President of Finance, Administration and Human Resources
Jacob Kriegel MD Co-Founder, Chief Medical Officer & Board Member
You’re viewing 3 of 5 executive team members. Get the full list »

Alleviant Medical Board Members (8)

Name Representing Role Since
Adam Berman Alleviant Medical Chief Executive Officer, President and Board Member 000 0000
Ashok Gowda Self Board Member 000 0000
Jacob Kriegel MD Alleviant Medical Co-Founder, Chief Medical Officer & Board Member 000 0000
Kirk Nielsen Vensana Capital Board Member 000 0000
Maria Berkman MD Broadview Ventures Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Alleviant Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alleviant Medical Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vensana Capital Venture Capital Minority 000 0000 000000 0
Boston Scientific Corporation Minority 000 0000 000000 0
Broadview Ventures Venture Capital Minority 000 0000 000000 0
S3 Ventures Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »